Radio Advisory 283: A candid conversation: Physicians on the front lines of GLP‑1 care
Jan 27, 2026
Spencer Nadolsky, MD, obesity and lipid specialist who builds direct-care models; Angela Fitch, MD, internal/pediatric physician focused on patient-centered metabolic homes; Florencia Halperin, MD, endocrinologist leading telehealth obesity care. They tackle GLP-1 hype, access and cost challenges. They debate medication-only approaches versus wraparound care. They explore payer strategies and what true, sustainable obesity care will require.
AI Snips
Chapters
Transcript
Episode notes
Hype Outpaces Evidence
- The industry is overhyping GLP-1s without sufficient data and controls.
- Clinicians must be optimistic but cautious to avoid untested practices.
Move Beyond The Scale
- Weight alone shouldn't be the primary metric for success with GLP-1s.
- Focus on treating obesity as a stigmatized health condition and improving overall health outcomes.
Provide Comprehensive Care
- Do not rely on single-prescription workflows for obesity care.
- Provide comprehensive services: nutrition, activity, behavioral health alongside medication.